GPS-Guided prostate radiation: could 3 doses be better than 5?
NCT ID NCT06117059
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether giving only 3 doses of high-precision radiation (SBRT) over 3 days is as safe and effective as the usual 5-dose schedule for men with low or intermediate risk prostate cancer. The radiation is guided by a special catheter that acts like a GPS, tracking the prostate's position in real time to protect nearby organs. The goal is to reduce side effects and make treatment more convenient.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radiation therapy (SBRT/SABR)
- What this could lead to
- If successful, this could offer a shorter, more convenient radiation schedule for early prostate cancer with fewer side effects.
- What could go wrong
- This is a small, early-phase study with only 100 participants. It is not yet proven that 3 doses are as safe or effective as the standard 5-dose regimen.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERMEDIATE RISK PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NHS Lothian
RECRUITINGEdinburgh, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can sound waves offer a lasting fix for prostate problems?
- A sharper eye on prostate cancer: could new imaging spare healthy tissue?
- Can a sound wave boost prostate cancer radiation precision?
- Could a smartwatch and remote coaching cut incontinence after prostate surgery?
- Could a placental wrap help men recover erections faster after prostate cancer surgery?
- AI model may forecast prostate cancer recurrence after surgery